ApoB and Arterial Plaque Formation

Every atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)) carries exactly one ApoB molecule on its surface. These particles can penetrate the arterial endothelium and become trapped in the subendothelial space, triggering an inflammatory cascade that leads to atherosclerotic plaque formation. The more ApoB particles circulating, the greater the probability of arterial penetration. This is why ApoB outperforms LDL-C as a predictor: two people with identical LDL cholesterol levels can have vastly different particle counts, and it is the particle count that drives risk.

1

Superior to LDL-C

Multiple studies show ApoB predicts cardiovascular events better than LDL cholesterol, especially when LDL and ApoB are discordant.

2

Particle Count Matters

Two people with identical LDL-C can have very different ApoB levels. The person with higher ApoB has significantly more risk.

3

Responds to Treatment

Statins, PCSK9 inhibitors, dietary changes, and exercise all reduce ApoB levels, making it useful for tracking treatment effectiveness.

Optimal ApoB Benchmarks

Functional Range (Cardiovascular Focused) Optimal: < 80 mg/dL; Ideal for high-risk: < 60 mg/dL
Standard Lab Range Standard lab range: < 130 mg/dL (often too lenient)

Common Questions

Why is ApoB better than LDL cholesterol?

LDL-C measures the amount of cholesterol inside LDL particles, but ApoB counts the actual particles. Since each particle can independently damage artery walls, the number of particles matters more than their cholesterol content.

What if my LDL is normal but ApoB is high?

This is called discordance and means you have more small, dense LDL particles. Your cardiovascular risk is higher than LDL alone suggests. Treatment should be guided by ApoB, not LDL-C.

How often should I test ApoB?

Annually for general monitoring. Every 3-6 months if you are actively treating elevated levels to track response to therapy.